Asset

Bortezomib

MAIA Biotechnology Inc. Common Stock

Revenue

No revenue reported in loaded filings.

Clinical trials (0)

No records yet.

FDA applications (1)

ApplicationTypeApplicant
NDA 215331NDAMAIA PHARMACEUTICALS INC

Marketed products (2)

  • BORTEZOMIB
  • BORTEZOMIB